Ion channels affected by the PERK activation were identified by treating MI mice with PERK inhibitor and using cardiac-specific PERK-KO mice, leading to a significant improvement in channel availability, expression, and conduction velocity. This evidence concerns the gene EIF2AK3 and myocardial infarction.